Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Christian Mirian; Anne Katrine Duun-Henriksen; Andrea Maier; Maria Møller Pedersen; Lasse Rehné Jensen; Asma Bashir; Thomas Graillon; Maya Hrachova; Daniela Bota; Martjin van Essen; Petar Spanjol; Christian Kreis; Ian Law; Helle Broholm; Lars Poulsgaard; Kåre Fugleholm; Morten Ziebell; Tina Munch; Martin A. Walter; Tiit Mathiesen

doi:10.2967/jnumed.120.249607

Research ArticleTheranostics

Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Christian Mirian, Anne Katrine Duun-Henriksen, Andrea Maier, Maria Møller Pedersen, Lasse Rehné Jensen, Asma Bashir, Thomas Graillon, Maya Hrachova, Daniela Bota, Martjin van Essen, Petar Spanjol, Christian Kreis, Ian Law, Helle Broholm, Lars Poulsgaard, Kåre Fugleholm, Morten Ziebell, Tina Munch, Martin A. Walter and Tiit Mathiesen

Journal of Nuclear Medicine April 2021, 62 (4) 507-513; DOI: https://doi.org/10.2967/jnumed.120.249607

Christian Mirian

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

2Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anne Katrine Duun-Henriksen

3Statistics and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrea Maier

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Møller Pedersen

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lasse Rehné Jensen

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Asma Bashir

4Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Graillon

5APHM, Department of Neurosurgery, La Timone Hospital, Marseille, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maya Hrachova

6Department of Neurology, UC Irvine Medical Center, Irvine, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniela Bota

6Department of Neurology, UC Irvine Medical Center, Irvine, California

7Department of Neurosurgery, UC Irvine Medical Center, Irvine, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martjin van Essen

8Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Petar Spanjol

2Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christian Kreis

2Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ian Law

4Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helle Broholm

9Department of Neuropathology, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lars Poulsgaard

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kåre Fugleholm

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

10Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Morten Ziebell

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tina Munch

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

10Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

11Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin A. Walter

2Department of Nuclear Medicine, University Hospital of Geneva, Geneva, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tiit Mathiesen

1Department of Neurosurgery, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

10Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

12Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 4

April 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Journal of Nuclear Medicine Apr 2021, 62 (4) 507-513; DOI: 10.2967/jnumed.120.249607

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Journal of Nuclear Medicine Apr 2021, 62 (4) 507-513; DOI: 10.2967/jnumed.120.249607

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands
Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study
Theranostics in Neurooncology: Heading Toward New Horizons
Intraarterial Administration Boosts 177Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients

Google Scholar

Theranostics

Determination of the Intralesional Distribution of Theranostic ¹²⁴I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer

Show more Theranostics

Clinical

Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?

Show more Clinical

Keywords

treatment-refractory meningioma
progressive meningioma
peptide receptor radionuclide therapy
somatostatin receptor

Main menu

User menu

Search

Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Clinical

Similar Articles

Keywords